Gwendolyn Binder - 28 May 2025 Form 4 Insider Report for Instil Bio, Inc. (TIL)

Role
Director
Signature
/s/ Sandeep Laumas, M.D. Attorney-in-Fact for Gwendolyn Binder
Issuer symbol
TIL
Transactions as of
28 May 2025
Net transactions value
$0
Form type
4
Filing time
29 May 2025, 19:13:10 UTC
Previous filing
19 May 2025
Next filing
21 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Binder Gwendolyn Director C/O INSTIL BIO, INC., 3963 MAPLE AVENUE, SUITE 350, DALLAS /s/ Sandeep Laumas, M.D. Attorney-in-Fact for Gwendolyn Binder 29 May 2025 0001791742

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TIL Stock Option (Right to Buy) Award $0 +6,500 $0.000000 6,500 28 May 2025 Common Stock 6,500 $26.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).